Treating pharyngeal gonorrhoea continues to remain a challenge

Affiliations

¹ Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton, VIC 3053, Australia. Electronic address: kongf@unimelb.edu.au.
² Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton, VIC 3053, Australia.

Comment

Fabian Y S Kong et al. Lancet Infect Dis. 2022 May.

. 2022 May;22(5):573-574.

doi: 10.1016/S1473-3099(21)00649-6. Epub 2022 Jan 19.

¹ Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton, VIC 3053, Australia. Electronic address: kongf@unimelb.edu.au.
² Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton, VIC 3053, Australia.

No abstract available

Comment on

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.
de Vries HJC, de Laat M, Jongen VW, Heijman T, Wind CM, Boyd A, de Korne-Elenbaas J, van Dam AP, Schim van der Loeff MF; NABOGO steering group. de Vries HJC, et al. Lancet Infect Dis. 2022 May;22(5):706-717. doi: 10.1016/S1473-3099(21)00625-3. Epub 2022 Jan 19. Lancet Infect Dis. 2022. PMID: 35065063 Clinical Trial.